Trends and experiences in liver retransplantation over 15 years

被引:128
作者
Pfitzmann, Robert [1 ]
Benscheidt, Birgit [1 ]
Langrehr, Jon Michael [1 ]
Schumacher, Guido [1 ]
Neuhaus, Ruth [1 ]
Neuhaus, Peter [1 ]
机构
[1] Humboldt Univ, Dept Surg, Charite, D-13353 Berlin, Germany
关键词
D O I
10.1002/lt.20904
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Compared to primary liver transplantation (LT), the inferior results in the outcome of liver retransplantation (re-LT) continue to be a major challenge. The purpose of this study was to analyze changes in and outcomes of re-LT over a period of 15 years at the Charite Virchow Clinic. Between 1989 and 2003, we performed 1,619 LTs and 157 re-LTs (9.7%) in 1,462 patients. A total of 119 retransplants (50 females, 69 males) were analyzed after consideration of exclusion criteria: recipient age <16 years, second re-LT, primary LT as split-liver or living-related LT, or combination with renal transplantation or Whipple operation. All patients received a whole-size organ. Mean follow-up was 62 months (6 days to 187 months). The main indications for re-LT were initial nonfunction (26.9%), recurrence of viral-induced hepatitis (20.2%), or acute and chronic rejection or thrombosis of the hepatic artery (both 16.8%). The main causes of death were bacterial infections (26.0%) as well as bleeding complications or recurrence of disease (both 16.0%) within the first postoperative month. Overall, 50 out of 119 patients (42%) died after re-LT, 26 patients within the first 3 months and 38 within 1 year. Overall patient survival was 89.9% after 1 month, 78.2% after 1 year, and 67.1% after 5 years. In conclusion, our study showed good clinical results after re-LT. Apart from the changing indications for re-LT with an increasing amount of initial organ failure and hepatic artery thrombosis, the analysis also showed a decreasing amount of complications such as rejection, ischemic type biliary lesions, and recurrence of the disease with unchanged outcome over a period of 15 years.
引用
收藏
页码:248 / 257
页数:10
相关论文
共 33 条
[21]  
NEUHAUS P, 1994, LANCET, V344, P423
[22]   COMPARISON OF FK506-BASED AND CYCLOSPORINE-BASED IMMUNOSUPPRESSION IN PRIMARY ORTHOTOPIC LIVER-TRANSPLANTATION - A SINGLE-CENTER EXPERIENCE [J].
NEUHAUS, P ;
BLUMHARDT, G ;
BECHSTEIN, WO ;
PLATZ, KP ;
JONAS, S ;
MUELLER, AR ;
LANGREHR, JM ;
LOHMANN, R ;
SCHATTENFROH, N ;
KNOOP, M ;
KECK, H ;
LEMMENS, P ;
RAAKOW, R ;
LUSEBRINK, R ;
SLAMA, KJ ;
LOBECK, H ;
HOPF, U .
TRANSPLANTATION, 1995, 59 (01) :31-40
[23]   Mycophenolatemofetil for immunosuppression after liver transplantation:: A follow-up study of 191 patients [J].
Pfitzmann, R ;
Klupp, J ;
Langrehr, JM ;
Uhl, M ;
Neuhaus, R ;
Settmacher, U ;
Steinmüller, T ;
Neuhaus, P .
TRANSPLANTATION, 2003, 76 (01) :130-136
[24]   Retransplantation of the liver in adults: outcome and predictive factors for survival [J].
Postma, R ;
Haagsma, EB ;
Peeters, PMJG ;
van den Berg, AP ;
Slooff, MJH .
TRANSPLANT INTERNATIONAL, 2004, 17 (05) :234-240
[25]   Supply of pre- and probiotics reduces bacterial infection rates after liver transplantation - A randomized, double-blind trial [J].
Rayes, N ;
Seehofer, D ;
Theruvath, T ;
Schiller, RA ;
Langrehr, JM ;
Jonas, S ;
Bengmark, S ;
Neuhaus, P .
AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 (01) :125-130
[26]   Results of retransplantation for recurrent hepatitis C [J].
Roayaie, S ;
Schiano, TD ;
Thung, SN ;
Emre, SH ;
Fishbein, TM ;
Miller, CM ;
Schwartz, ME .
HEPATOLOGY, 2003, 38 (06) :1428-1436
[27]   Validation and refinement of survival models for liver retransplantation [J].
Rosen, HR ;
Prieto, M ;
Casanovas-Taltavull, T ;
Cuervas-Mons, V ;
Guckelberger, O ;
Muiesan, P ;
Strong, RW ;
Bechstein, WO ;
O'Grady, J ;
Zaman, A ;
Chan, B ;
Berenguer, J ;
Williams, R ;
Heaton, N ;
Neuhaus, P .
HEPATOLOGY, 2003, 38 (02) :460-469
[28]   Incidence and survival rate of hepatic retransplantation in a series of 300 orthotopic liver transplants [J].
Sánchez-Bueno, F ;
Acosta, F ;
Ramirez, P ;
Robles, R ;
Rodriguez, JM ;
Munitiz, V ;
Rios, A ;
Parrilla, P .
TRANSPLANTATION PROCEEDINGS, 2000, 32 (08) :2671-2672
[29]  
Wang Zi-Fa, 2004, Hepatobiliary Pancreat Dis Int, V3, P175
[30]   Poor survival after liver retransplantation: Is hepatitis C to blame? [J].
Watt, KDS ;
Lyden, ER ;
McCashland, TM .
LIVER TRANSPLANTATION, 2003, 9 (10) :1019-1024